30 Years of Evidence

Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.

Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma

S Kaidar-Person O, Price A, Schreiber E, Zagar TM, Chen RC | Clin Genitourin Cancer | 2017

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

Senger C, Conti A, Kluge A, Pasemann D, Kufeld M, Acker G, Lukas M, Grün A, Kalinauskaite G, Budach V, Waiser J, Stromberger C | BMC Urol | 2019

Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological Outcomes

Michael Staehler, Tina Schuler, Annabel Spek, Severin Rodler, Alexander Tamalunas, Christoph Fürweger, Alexander Muacevic | Cureus | 2022

Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis

Felix Ehret, David Kaul, Markus Kufeld, Clara Vom Endt, Volker Budach, Carolin Senger , Christoph Fürweger , Alfred Haidenberger , Alexander Muacevic | J Cancer Res Clin Oncol | 2022

Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer

Dagoglu N, Callery M, Moser J, Tseng J, Kent T, Bullock A, Miksad R, Mancias JD, Mahadevan A | J Cancer | 2016

Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer

Lischalk JW, Burke A, Chew J, Elledge C, Gurka M, Marshall J, Pishvaian M, Collins S, Unger K. | J Gastrointest Cancer | 2018

Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable pancreatic cancer

Shen ZT, Zhou H, Li AM, Ji XQ, Jiang CC, Yuan X, Li B, Zhu XX, Huang GC | J Cancer Res Clin Oncol | 2020

Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements

Yoon K, Kwak J, Cho B, Park JH, Yoon SM, Lee SW, Kim JH | PLoS One | 2016

Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases

Stintzing S, Einem JV, Fueweger C, Haidenberger A, Fedorov M, Muavcevic A | Cancer Res Treat | 2019

Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases

Anstadt EJ, Shumway R, Colasanto J, Grew D | J Gastrointest Oncol | 2019

Challenges of BCLC stage C hepatocellular carcinoma: Results of a single-institutional experience on stereotactic body radiation therapy

Que J, Lin CH, Lin LC, Ho CH | Medicine (Baltimore) | 2020

Cyberknife Radiosurgery in Hepatocellular Carcinoma

Memon B, Kadri S, Sultana N, Saeed K, Ahmed N, Mahmood T | J Coll Physicians Surg Pak | 2021

Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study

Dutta D, Tatineni T, Yarlagadda S, Gupte A, Reddy SK, Madhavan R, Nair H, Sasidharan A, Kannan R, Pottayil SG, Holla R, Sudhindran S | Indian J Gastroenterol | 2021